" class="no-js "lang="en-US"> Amanda Pritchard Archives - Medtech Alert
Friday, April 19, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Major Plan to Recover Urgent and Emergency NHS Care Services

The NHS and the government will publish a new blueprint today to help recover urgent […]

World’s First Chemo Drone Delivery Announced on NHS Birthday

NHS cancer patients will be the first in the world to benefit from chemotherapy delivered […]

High Street Pharmacies Spot Cancers In New NHS Early Diagnosis Drive

Staff in high street pharmacies will be funded to spot signs of cancer as part […]

One Million Checks Delivered By NHS ‘One Stop Shops’

NHS ‘one stop shops’ have delivered over one million checks and tests since the rollout […]

Babies To Get New Test For Eye Cancer In The Womb To Save Their Sight

A life-saving test that allows doctors to spot a rare form of eye cancer in […]

New State-Of-The-Art NHS Hospital To Help Tackle Covid Backlog

A new ‘planned care’ hospital dedicated to non-emergency treatment is due to open in Berkshire […]

NHS Announces £127m Maternity Boost for Patients and Families  

The NHS in England has today announced a £127 million funding boost for maternity services across […]

Life-extending Injection for Blood Cancer Available on the NHS

A life-extending injection for a fatal form of blood cancer will be available to around […]

Hundreds of Patients to Benefit From Revolutionary Lung Cancer Drug On The NHS

A revolutionary targeted drug for lung cancer will be made available to anyone who is […]

NHS Publishes Electives Recovery Plan To Boost Capacity And Give Power To Patients

The NHS and government have today set out a blueprint to address backlogs built up during the Covid […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more